CD79A and cancer: In conclusion, our findings explore the cancer-promoting role of IL-21R in MASH-driven hepatocarcinogenesis and elucidate the mechanism by which IL-21R activates IgA via the IL-21R-STAT-1-c-Jun/c-Fos-IgA regulatory axis.